Literature DB >> 15093745

Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior.

Annika Jögi1, Johan Vallon-Christersson, Linda Holmquist, Håkan Axelson, Ake Borg, Sven Påhlman.   

Abstract

We have recently found that cells derived from human neuroblastoma, a sympathetic nervous system (SNS) tumor, dedifferentiate and acquire a neural crest-like phenotype when exposed to hypoxia. In the present study, global analysis of gene expression and quantitative PCR of relevant genes showed that hypoxia provokes a general adaptive response in neuroblastoma cells and confirm loss of the neuronal phenotype and gain of stem-cell characteristics. Of the approximately 17,000 genes and ESTs analyzed, 199 were consistently upregulated and 36 were downregulated more than 2-fold by hypoxia. As anticipated, several genes involved in glucose and iron metabolism and neovascularization were upregulated, the latter group we here show to include the gene encoding chromogranin C and its cleavage product, secretoneurin, a vascular smooth muscle cell mitogen. We also observed upregulation of genes implicated in cell survival and growth, such as vascular endothelial growth factor (VEGF), neuropilin 1, adrenomedullin, and IGF-2. Several metallothioneins, which are linked to tumor drug resistance, were upregulated, whereas the expression of MDR1 decreased. In hypoxic neuroblastoma cells, proneuronal lineage specifying transcription factors, and their dimerization partner E2-2, were downregulated, whereas their inhibitors Id2 and HES-1 were induced, providing a molecular mechanism for the hypoxia-provoked dedifferentiation of neuroblastoma cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15093745     DOI: 10.1016/j.yexcr.2004.01.013

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  44 in total

1.  Individualized Medicine in Ovarian Cancer: Are We There Yet?

Authors:  Shannon N Westin; Robert L Coleman
Journal:  Gynecol Oncol       Date:  2017-02       Impact factor: 5.482

2.  Protein kinase Cα suppresses the expression of STC1 in MDA-MB-231 breast cancer cells.

Authors:  Louise Cornmark; Gry Kalstad Lønne; Annika Jögi; Christer Larsson
Journal:  Tumour Biol       Date:  2011-07-01

3.  Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma.

Authors:  Kelly R Ostler; Qiwei Yang; Timothy J Looney; Li Zhang; Aparna Vasanthakumar; Yufeng Tian; Masha Kocherginsky; Stacey L Raimondi; Jessica G DeMaio; Helen R Salwen; Song Gu; Alexandre Chlenski; Arlene Naranjo; Amy Gill; Radhika Peddinti; Bruce T Lahn; Susan L Cohn; Lucy A Godley
Journal:  Cancer Res       Date:  2012-07-18       Impact factor: 12.701

Review 4.  Improving outcomes in difficult bone cancers using multimodality therapy, including radiation: physician and nursing perspectives.

Authors:  Pete Anderson; Maritza Salazar-Abshire
Journal:  Curr Oncol Rep       Date:  2006-11       Impact factor: 5.075

Review 5.  Role of the sympathetic autonomic nervous system in hypoxic remodeling of the fetal cerebral vasculature.

Authors:  Olayemi O Adeoye; Jinjutha Silpanisong; James M Williams; William J Pearce
Journal:  J Cardiovasc Pharmacol       Date:  2015-04       Impact factor: 3.105

6.  The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF.

Authors:  Sophie Beyer; Malene Maag Kristensen; Kim Steen Jensen; Jens Vilstrup Johansen; Peter Staller
Journal:  J Biol Chem       Date:  2008-11-04       Impact factor: 5.157

7.  Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer.

Authors:  R J Shaw; M M Omar; S Rokadiya; F A Kogera; D Lowe; G L Hall; J A Woolgar; J Homer; T Liloglou; J K Field; J M Risk
Journal:  Br J Cancer       Date:  2009-07-07       Impact factor: 7.640

8.  Identification of multiple hypoxia signatures in neuroblastoma cell lines by l1-l2 regularization and data reduction.

Authors:  Paolo Fardin; Andrea Cornero; Annalisa Barla; Sofia Mosci; Massimo Acquaviva; Lorenzo Rosasco; Claudio Gambini; Alessandro Verri; Luigi Varesio
Journal:  J Biomed Biotechnol       Date:  2010-06-28

9.  Bcl6 is expressed in neuroblastoma: tumor cell type-specific expression predicts outcome.

Authors:  Aghiad Chamdin; Jason A Jarzembowski; Chitra Subramanian; Rork Kuick; Julia Shin-Jung Lee; Roland Ps Kwok; Valerie P Castle; Anthony W Opipari
Journal:  Transl Oncol       Date:  2009-08-18       Impact factor: 4.243

10.  The l1-l2 regularization framework unmasks the hypoxia signature hidden in the transcriptome of a set of heterogeneous neuroblastoma cell lines.

Authors:  Paolo Fardin; Annalisa Barla; Sofia Mosci; Lorenzo Rosasco; Alessandro Verri; Luigi Varesio
Journal:  BMC Genomics       Date:  2009-10-15       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.